Clinical Trials on HER2 Positive Gastric Cancer in Singapore
Total 77 results
-
National Cancer Centre, SingaporeCompletedHER 2 Positive Advanced Gastric CancerSingapore
-
MacroGenicsZai Lab (Shanghai) Co., Ltd.Active, not recruitingGastric Cancer | Gastroesophageal Junction Cancer | HER2-positive Gastric CancerKorea, Republic of, United States, China, Italy, Taiwan, Germany, Singapore, United Kingdom, Poland
-
National Cancer Centre, SingaporeMSD Pharma (Singapore) Pte LtdRecruitingHormone Receptor-Positive HER2-Negative Advanced Breast CancerSingapore
-
Sidney Kimmel Comprehensive Cancer Center at Johns...CompletedStage T3-4NxM0 Gastric CancerSingapore
-
Novartis PharmaceuticalsCompletedAdvanced HER2-positive Breast CancerFrance, Italy, Germany, Singapore, Sweden, Spain, United Kingdom, United States
-
National University Hospital, SingaporeYonsei University; National Cancer Centre, SingaporeUnknownRecurrent Gastric CancerSingapore
-
National University Hospital, SingaporeAdagene IncRecruitingAdvanced Solid Tumor | HER2-negative Breast CancerSingapore
-
Changi General HospitalSingapore General HospitalCompletedEarly Gastric Cancer | Barrett EsophagusSingapore
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive, HER2-negative, Advanced Breast CancerJapan, Hong Kong, Singapore
-
Changi General HospitalRecruitingGastric Cancer | Gastric Intestinal Metaplasia | Gastric DysplasiaSingapore
-
Changi General HospitalCompletedGastric Cancer | Gastric Intestinal MetaplasiaSingapore
-
MiRXES Pte LtdRecruitingBreast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Esophageal Cancer | Ovarian Cancer | Prostate Cancer | Thoracic Cancer | Liver CancerSingapore
-
University of MalayaNational University Hospital, Singapore; Merck Sharp & Dohme LLC; Cancer Research...RecruitingHER2-Negative Breast CancerSingapore, Malaysia
-
National Cancer Centre, SingaporeNovartisTerminatedGastric Cancer | Colorectal CancerSingapore
-
National University Hospital, SingaporeUnknown
-
National University Hospital, SingaporeNational University of SingaporeUnknownBreast Cancer | Gastric CancerSingapore
-
National University Hospital, SingaporeNational Cancer Centre, SingaporeUnknownErbB2-Positive Stage I-III Breast CancerSingapore
-
National University Hospital, SingaporeUnknownGastric Cancer | Esophageal Cancer | Esophagogastric Junction CancerSingapore
-
National University Hospital, SingaporeEndofotonics Pte LtdRecruitingGastric CancerSingapore
-
National University Hospital, SingaporeBristol-Myers Squibb; OncoTherapy Science, Inc.Recruiting
-
National University Hospital, SingaporeNational Cancer Centre, SingaporeUnknown
-
National University Hospital, SingaporeUnknown
-
National University Hospital, SingaporeTan Tock Seng Hospital; MiRXES Pte LtdCompleted
-
Novartis PharmaceuticalsCompletedAdvanced Gastric Cancer | Gastro-esophageal Junction CancerUnited States, France, Italy, Taiwan, United Kingdom, Turkey, Germany, Singapore, Australia, Russian Federation, Korea, Republic of, Switzerland, Netherlands, Canada
-
National University Hospital, SingaporeUnknown
-
National University Hospital, SingaporeUnknown
-
Seagen Inc.RecruitingHER2-positive Breast CancerUnited States, Australia, Austria, Belgium, Canada, China, Denmark, France, Germany, Israel, Italy, Japan, Korea, Republic of, Netherlands, Singapore, Spain, Sweden, Switzerland, Taiwan, United Kingdom
-
National University Hospital, SingaporeTan Tock Seng HospitalUnknownGastric CancerSingapore
-
Hoffmann-La RocheActive, not recruitingEstrogen Receptor-Positive, HER2-Negative, Locally Advanced or Metastatic Breast CancerUnited States, Korea, Republic of, China, Poland, Taiwan, Turkey, United Kingdom, Australia, Argentina, Germany, Singapore, Thailand, Israel, Russian Federation, Ukraine, Brazil, South Africa
-
Chinese University of Hong KongChangi General Hospital; Kosin University Gospel Hospital; Shizuoka Cancer Center and other collaboratorsCompletedEarly Gastric Cancer | Gastric NeoplasmJapan, Singapore, Korea, Republic of, Hong Kong
-
National University Hospital, SingaporeRecruitingNon Small Cell Lung Cancer | EGFR Positive Non-small Cell Lung CancerSingapore
-
Daiichi Sankyo, Inc.AstraZeneca; NSABP Foundation Inc; German Breast Group; Spanish Breast Cancer Research...Active, not recruitingHER2-Positive Primary Breast Cancer | Residual Invasive Breast CancerUnited States, Spain, France, Germany, Korea, Republic of, United Kingdom, Denmark, Israel, Belgium, Taiwan, Chile, Italy, Japan, Peru, Portugal, China, Turkey, Canada, Ireland, Australia, Greece, Czechia, Singapore, Poland, Romania, Arge... and more
-
National Healthcare Group, SingaporeChinese University of Hong Kong; Tan Tock Seng Hospital; Changi General HospitalCompletedStomach Cancer | Gastric Cancer | GastrectomySingapore, Hong Kong
-
National University Hospital, SingaporeUnknownBreast Cancer | Gastric Cancer | Prostate Cancer | Non-small Cell Lung Cancer | Solid TumorsSingapore
-
National Cancer Centre, SingaporeINTRA-IMMUSG PRIVATE LIMITEDRecruitingHepatocellular Carcinoma | Gastric Cancer | Advanced Solid TumorSingapore
-
Genentech, Inc.RecruitingEstrogen Receptor (ER)-Positive, HER2-negative, Locally Advanced or Metastatic Breast CancerKorea, Republic of, United States, Spain, Taiwan, United Kingdom, Japan, Germany, Argentina, Turkey, Greece, Italy, Singapore, South Africa
-
National University Hospital, SingaporeSeverance Hospital; Wakayama Medical UniversityUnknownGastric CancerSingapore, Korea, Republic of, Japan
-
National University Hospital, SingaporeUnknownGastric CancerSingapore
-
National University Hospital, SingaporePrince of Wales Hospital, Shatin, Hong Kong; Apollo Gleneagles Hospitals, KolkataUnknownGastric Cancer | Colon CancerSingapore, India, China
-
AstraZenecaActive, not recruitingCervical Cancer | Ovarian Cancer | Pharmacokinetics | Endometrial Cancer | Pharmacodynamics | Safety and Tolerability | Advanced Solid Malignancy | Tumour Response | Advanced or Metastatic Breast Cancer | PIK3CA | AKT1 | PTEN | ER Positive | HER2 PositiveUnited States, Italy, Canada, France, Japan, United Kingdom, Spain, Netherlands, Denmark, Singapore
-
Chinese University of Hong KongRecruitingGastric Cancer | Intestinal Metaplasia | Atrophic GastritisHong Kong, Japan, Singapore, Thailand
-
Cancer Therapeutics Research GroupNational Cancer Institute (NCI)CompletedGastric CancerAustralia, Singapore, Hong Kong, Korea, Republic of
-
Bristol-Myers SquibbClovis Oncology, Inc.CompletedAdvanced Gastric CancerUnited States, Israel, Netherlands, Canada, Italy, Australia, Germany, Singapore, Switzerland
-
National Cancer Centre, SingaporeGuardant Health AMEA, Inc.RecruitingNon-small Cell Lung Cancer | ALK-Positive Lung CancerKorea, Republic of, Hong Kong, Malaysia, Singapore
-
BeiGeneCompletedAdvanced or Inoperable Gastric CancerUnited States, Hungary, Spain, China, Hong Kong, Japan, Australia, Taiwan, Belgium, Czechia, Singapore, France, Poland, United Kingdom, Romania, Russian Federation, Georgia
-
MacroGenicsMerck Sharp & Dohme LLCCompletedStomach Cancer | Gastric Cancer | Esophageal CancerKorea, Republic of, United States, Taiwan, Singapore, Canada
-
ASLAN PharmaceuticalsCompletedGastric CancerEstonia, Hong Kong, Korea, Republic of, Lithuania, Malaysia, Singapore, Taiwan, Thailand
-
AmgenRecruitingGastric Cancer | Gastroesophageal Junction CancerKorea, Republic of, Taiwan, Japan, Singapore, United States
-
Puma Biotechnology, Inc.CompletedHER2+ Metastatic Breast Cancer (MBC)United States, Canada, Spain, Singapore, Korea, Republic of, Taiwan, United Kingdom, Israel, Australia, Japan, Hong Kong, Finland, Ireland, Italy, France, Portugal, Germany, Sweden, Belgium, Brazil, Czechia, Switzerland, Argentina, Au... and more
-
National Cancer Centre, SingaporePfizerActive, not recruitingNSCLC Stage IV | NSCLC Stage IIIB | Recurrent NSCLC | NSCLC Stage IIIC | EGFR Positive Non-Small Cell Lung CancerKorea, Republic of, Hong Kong, Thailand, Singapore, Malaysia